Geode Capital Management’s OptimizeRx OPRX Stock Holding History

Geode Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46M	Sell	392,129 -4,339	-1%	-$40.3K	﹤0.01%	3045
2025 Q4	$4.86M	Buy	396,468 +13,291	+3%	+$217K	﹤0.01%	2794
2025 Q3	$7.86M	Sell	383,177 -16,371	-4%	-$260K	﹤0.01%	2554
2025 Q2	$5.39M	Sell	399,548 -8,127	-2%	-$88.9K	﹤0.01%	2691
2025 Q1	$3.53M	Buy	407,675 +7,054	+2%	+$43.1K	﹤0.01%	2830
2024 Q4	$1.95M	Buy	400,621 +4,821	+1%	+$26.9K	﹤0.01%	3138
2024 Q3	$3.06M	Sell	395,800 -20,126	-5%	-$179K	﹤0.01%	2980
2024 Q2	$4.16M	Buy	415,926 +30,088	+8%	+$331K	﹤0.01%	2832
2024 Q1	$4.69M	Buy	385,838 +7,325	+2%	+$106K	﹤0.01%	2739
2023 Q4	$5.42M	Buy	378,513 +35,417	+10%	+$340K	﹤0.01%	2661
2023 Q3	$2.67M	Buy	343,096 +7,443	+2%	+$81K	﹤0.01%	2971
2023 Q2	$4.8M	Buy	335,653 +12,063	+4%	+$172K	﹤0.01%	2703
2023 Q1	$4.73M	Buy	323,590 +8,030	+3%	+$134K	﹤0.01%	2648
2022 Q4	$5.3M	Sell	315,560 -15,548	-5%	-$269K	﹤0.01%	2628
2022 Q3	$4.91M	Buy	331,108 +3,983	+1%	+$78.7K	﹤0.01%	2687
2022 Q2	$8.96M	Buy	327,125 +5,491	+2%	+$163K	﹤0.01%	2337
2022 Q1	$12.1M	Buy	321,634 +15,951	+5%	+$706K	﹤0.01%	2224
2021 Q4	$19M	Buy	305,683 +1,955	+0.6%	+$148K	﹤0.01%	1993
2021 Q3	$26M	Buy	303,728 +16,323	+6%	+$1.02M	﹤0.01%	1774
2021 Q2	$17.8M	Buy	287,405 +17,913	+7%	+$912K	﹤0.01%	2053
2021 Q1	$13.1M	Buy	269,492 +38,832	+17%	+$1.87M	﹤0.01%	2164
2020 Q4	$7.19M	Buy	230,660 +30,933	+15%	+$758K	﹤0.01%	2388
2020 Q3	$4.16M	Sell	199,727 -1,058	-0.5%	-$18.2K	﹤0.01%	2508
2020 Q2	$2.62M	Buy	200,785 +20,212	+11%	+$220K	﹤0.01%	2696
2020 Q1	$1.64M	Buy	180,573 +12,998	+8%	+$123K	﹤0.01%	2787
2019 Q4	$1.72M	Buy	167,575 +10,278	+7%	+$116K	﹤0.01%	3078
2019 Q3	$2.28M	Buy	157,297 +17,402	+12%	+$269K	﹤0.01%	2866
2019 Q2	$2.27M	Buy	139,895 +65,918	+89%	+$890K	﹤0.01%	2872
2019 Q1	$940K	Buy	73,977 +13,116	+22%	+$171K	﹤0.01%	3186
2018 Q4	$667K	Buy	60,861 +45,440	+295%	+$672K	﹤0.01%	3262
2018 Q3	$277K	Buy	+15,421	New	+$194K	﹤0.01%	3652

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management's OPRX Position: Q1 2026 in Review

Geode Capital Management reduced its OptimizeRx (OPRX) stake by 1.1% in Q1 2026, selling an estimated $40.3K and leaving 392,129 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

Geode Capital Management first reported a position in OPRX in Q3 2018 and has held it in 31 quarters since. The position peaked at $26M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Geode Capital Management held 392,129 shares of OptimizeRx worth $2.46M as of Q1 2026.
Geode Capital Management sold 4,339 OptimizeRx shares in Q1 2026, an estimated $40.3K.
OptimizeRx made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3045 holding.
Geode Capital Management first reported a position in OptimizeRx in Q3 2018 and has held it in 31 quarters since.
Geode Capital Management's OptimizeRx position peaked at $26M in Q3 2021.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.